Dr. Robert Jacobson, medical director of Mayo Clinic's Primary Care Immunization Program, says there are tools to help reduce ...

The expense associated with training, medical evaluations, and respiratory protection equipment will be born by Michigan Tech. Supervisors, managers, and faculty are responsible for ensuring that the ...

Below is Validea's guru fundamental report for CAPRICOR THERAPEUTICS INC (CAPR). Of the 22 guru strategies we follow, CAPR rates highest using our Small-Cap Growth Investor model based on the ...

Despite a relatively slow start to respiratory disease season, low vaccination rates threaten that trend and the rapid rise of some illnesses is already putting children at increased risk.

“Initial diagnoses lead us to think it is a respiratory disease, but we have to wait for laboratory results.” Of the hospitalized patients, 17 died due to respiratory problems. Kaseya stressed ...

Dec. 25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Capricor's strong financial health and cash runway into 2027 support its high-risk/high-reward investment profile, making CAPR a speculative "buy" within a barbell portfolio. HOPE-2 was a Phase 2 ...

Air purifiers purchased during the pandemic to zap airborne coronavirus particles can also help reduce the amount of allergens and other irritants that have been linked to asthma and other respiratory ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Capricor Therapeutics (CAPR – Research Report) today and set a price target of $35.00. The company’s shares closed last Friday ...

In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report), with a price target of $43.00. The company’s shares ...